Publication | Open Access

Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseImmunologyCartilage DegenerationOsteoarthritisProspective RandomizedChronic Musculoskeletal ConditionMedicineInflammatory DiseaseRheumatoid Arthritis